ProMetic Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: stocker22	11/23/2017 9:33:11 PM
	Read Replies (1) of 250

New findings from late-stage clinical trial evaluating IVIG in patients suffering from primary immunodeficiencies confirm Prometic's hyperimmune product platform, also enable the company to complete the clinical portion of its New Drug Submission with Health Canada crweworld.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next